Increased plasma levels of adipokines in preeclampsia: Relationship to placenta and adipose tissue gene expression

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 2, 2006, Pages

  Haugen, Fred ^a   Ranheim, Trine ^b   Harsem, Nina K ^c   Lips, Esther ^a   Staff, Anne C ^c   Drevon, Christian A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adiponectin; Leptin; Pregnancy; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; MESSENGER RNA; RESISTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BODY MASS; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; DIET RESTRICTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MATERNAL PLASMA; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; PREGNANCY; TISSUE DISTRIBUTION;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; FEMALE; HUMANS; LEPTIN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RESISTIN; TISSUE DISTRIBUTION;

EID: 33644851260     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00020.2005     Document Type: Article

References (60)

1. Anim-Nyame N, Sooranna SR, Steer PJ, and Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 15: 2033-2036, 2000.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
3. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, and Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11: 997-1001, 2003.
4. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, and Lazar MA. Regulation of fasted blood glucose by resistin. Science 303: 1195-1198, 2004.
5. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, and Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527-E533, 2003.
6. Chandran M, Phillips SA, Ciaraldi T, and Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 26: 2442-2450, 2003.
7. Chen D, Dong M, Fang Q, He J, Wang Z, and Yang X. Alterations of serum resistin in normal pregnancy and preeclampsia. Clin Sci (Lond) 108: 81-84, 2004.
8. Clausen T, Djurovic S, Reseland JE, Berg K, Drevon CA, and Henriksen T. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 23: 380-385, 2002.
9. Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, and Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 27: 274-275, 2004.
10. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, and Considine RV. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88: 5452-5455, 2003.
11. Ehrenberg HM, Huston-Presley L, and Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 189: 944-948, 2003.
12. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Mohlig M, Pfeiffer AF, Luft FC, and Sharma AM. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52: 942-947, 2003.
13. Furuhashi M, Ura N, Higashiura K, Murakami H, and Shimamoto K. Circulating resistin levels in essential hypertension. Clin Endocrinol (Oxf) 59: 507-510, 2003.
14. Greer IA, Lyall F, Perera T, Boswell F, and Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 84: 937-940, 1994.
15. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, and Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
16. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, and Smith SR. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89: 1844-1848, 2004.
17. Hoggard N, Haggarty P, Thomas L, and Lea RG. Leptin expression in placental and fetal tissues: does leptin have a functional role? Biochem Soc Trans 29: 57-63, 2001.
18. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
19. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, and Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133, 2001.
20. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, and Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 42: 62-66, 2003.
21. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, and Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51: 2207-2213, 2002.
22. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, and Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26: 1745-1751, 2003.
23. Laml T, Preyer O, Hartmann BW, Ruecklinger E, Soeregi G, and Wagenbichler P. Decreased maternal serum leptin in pregnancies complicated by preeclampsia. J Soc Gynecol Investig 8: 89-93, 2001.
24. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, and Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856, 2003.
25. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, and Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58, 2002.
26. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221: 286-289, 1996.
27. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, and Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161, 1995.
28. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, and Matsuzawa Y. Adiponectin in essential hypertension. J Nephrol 15: 507-511, 2002.
29. Matsubara M, Maruoka S, and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764-2769, 2002.
30. Matsubara M, Maruoka S, and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147: 173-180, 2002.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
32. McCarthy JF, Misra DN, and Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 180: 731-736, 1999.
33. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y, and Nakao K. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 83: 3225-3229, 1998.
34. Moon B, Kwan JJ, Duddy N, Sweeney G, and Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 285: E106-E115, 2003.
35. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114: 232-239, 2004.
36. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, and Cooper DM. Adipocytokines, body composition, and fitness in children. Pediatr Res 53: 148-152, 2003.
37. O'Brien TE, Ray JG, and Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14: 368-374, 2003.
38. Rajala MW, Obici S, Scherer PE, and Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111: 225-230, 2003.
39. Ramsay JE, Jamieson N, Greer IA, and Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 42: 891-894, 2003.
40. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, and Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 83: 341-347, 2004.
41. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, and Drevon CA. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42: 743-750, 2001.
42. Roberts JM and Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451, 1993.
43. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, and McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989.
44. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, and Olefsky JM. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114: 224-231, 2004.
45. Seely EW and Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 88: 2393-2398, 2003.
46. Shetty GK, Economides PA, Horton ES, Mantzoros CS, and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450-2457, 2004.
47. Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, and Murphy LJ. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf) 58: 736-742, 2003.
48. Sivan E, Whittaker PG, Sinha D, Homko CJ, Lin M, Reece EA, and Boden G. Leptin in human pregnancy: the relationship with gestational hormones. Am J Obstet Gynecol 179: 1128-1132, 1998.
49. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001.
50. Trayhurn P and Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339, 2001.
51. Visser W, Beckmann I, Bremer HA, Lim HL, and Wallenburg HC. Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 101: 1081-1082, 1994.
52. Volarova de Courten B, Degawa-Yamauchi M, Considine RV, and Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53: 1279-1284, 2004.
53. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, and Hotamisligil GS. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276: 25651-25653, 2001.
54. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, and Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.
55. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, and Saruta T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103: 137-142, 2002.
56. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, and Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003.
57. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, and Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88: 1730-1736, 2003.
58. Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, Takemura M, and Fujii S. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 88: 1394-1397, 2003.
59. Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, Catalano F, Tanaka S, Ouchi N, Kihara S, Funahashi T, and Matsuzawa Y. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl 84: S98-S102, 2003.
60. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, and Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13: 134-141, 2002.